SOPHiA GENETICS (SOPH) HR chief sells 10K shares under 10b5-1 plan
Rhea-AI Filing Summary
SOPHiA GENETICS SA (SOPH) reported that Chief People Officer Manuela Valente exercised share options for 10,000 Ordinary Shares at an exercise price of $3.20 per share and, on the same date, sold 10,000 Ordinary Shares at a weighted average price of $7.9439 per share. The transactions were made pursuant to a duly adopted Rule 10b5-1(c) trading plan. The exercised options were fully vested, and following this exercise she continues to hold 554,276 derivative share options across remaining grant tranches with varying exercise prices, with the exercised option series expiring on January 1, 2029.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 10,000 shares ($47K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Valente Manuela
Role
Chief People Officer
Sold
10,000 shs ($79K)
Approx. gross sale proceeds
$79K
Approx. exercise cost
$32K
Approx. pre-tax spread
$47K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Share Option (Right to Buy) F1, F3, F4 | 10,000 | $0.00 | $0.00 |
| Exercise | Ordinary Shares F1 | 10,000 | $3.20 | $32K |
| Sale | Ordinary Shares F1, F2 | 10,000 | $7.9439 | $79K |
Holdings After Transaction:
Share Option (Right to Buy) — 0 shares (Direct);
Ordinary Shares — 210,450 shares (Direct)
Footnotes (4)
- F1. Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.90 to $8.01, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The share options are fully vested and exercisable.
- F4. Following the transaction reported on this line, the Reporting Person holds an aggregate total of 554, 276 derivative share options across all remaining grant tranches with varying exercise prices.
Key Figures
Options Exercised: 10,000 share options
Exercise Price: $3.20 per share
Shares Sold: 10,000 Ordinary Shares
+4 more
7 metrics
Options Exercised
10,000 share options
Share Option (Right to Buy) exercised on August 19, 2026
Exercise Price
$3.20 per share
Exercise price for 10,000 share options into Ordinary Shares
Shares Sold
10,000 Ordinary Shares
Sale reported for August 19, 2026
Weighted Average Sale Price
$7.9439 per share
Weighted average for sales between $7.90 and $8.01
Remaining Derivative Share Options
554,276 options
Aggregate derivative share options held after this transaction
Option Expiration Date
January 1, 2029
Expiration date of the exercised share option grant
Sale Price Range
$7.90–$8.01 per share
Price range of individual sale trades in reported transaction
Key Terms
Rule 10b5-1(c), weighted average price, derivative security, Ordinary Shares
4 terms
Rule 10b5-1(c) regulatory
"Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c)."
Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What insider transaction did SOPH Chief People Officer Manuela Valente report on this Form 4?
Manuela Valente exercised 10,000 share options for SOPHiA GENETICS SA Ordinary Shares at an exercise price of $3.20 per share and sold 10,000 shares on the same date at a weighted average price of $7.9439 per share.
How many SOPH options did Manuela Valente exercise and what was the strike price?
She exercised 10,000 share options for Ordinary Shares of SOPHiA GENETICS SA at an exercise price of $3.20 per share. The options were fully vested and exercisable at the time of the transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
